IP Library Patent Application 16826767
Patent Application
App. No. 16/826,767

COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS USING SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/826,767
Abstract

Disclosed are the use of fluorine substituted olefins, including tetra- and penta-fluoropropenes, in a variety of applications, including in methods of depositing catalyst on a solid support, methods of sterilizing articles, cleaning methods and compositions, methods of applying medicaments, fire extinguishing/suppression compositions and methods, flavor formulations, fragrance formulations and inflating agents.

Claims (33)

1 . A method of depositing catalyst on a solid support comprising precipitating particles of said catalyst from a compound of formula I in a supercritical or near supercritical state:

XCF z R 3-z   (I)

where X is a C2 or a C3 unsaturated, substituted or unsubstituted, radical, R is independently Cl, F, Br, I or H, and z is 1 to 3.

56 . The method of claim 1 wherein said at least one fluoroalkene is a compound of Formula II:

where each R is independently Cl, F, Br, I or H

R′ is (CR2)nY,

Y is CRF2

and n is 0 or 1.

2 . The method of claim 1 wherein Y is CF3.

3 . The method of claim 2 wherein at least one R on the unsaturated terminal carbon is H.

4 . The method of claim 3 wherein n is 0.

5 . The method of claim 1 wherein n is 0.

6 . The method of claim 1 wherein Y is CF3 and n is 0.

7 . The method of claim 1 wherein said at least one fluoroalkene comprises at least one tetrafluoropropene (HFO-1234).

8 . The method of claim 7 wherein said at least one fluoroalkene further comprises at least one pentafluoropropene (HFO-1225).

9 . The method of claim 7 wherein said at least one tetrafluoropropene comprises 1,3,3,3-tetrafluoropropene (HFO-1234ze).

10 . (canceled)

11 . (canceled)

12 . (canceled)

13 . A method of treating an article or an organism with a composition comprising: providing a composition comprising at least one fluoroalkene in accordance with Formula I:

XCF z R3- z   (I)

where X is a C2 or a C3 unsaturated, substituted or unsubstituted, alkyl radical, R is independently Cl, F, Br, I or H, and z is 1 to 3; and introducing said composition to the article or the organism.

14 . The method of claim 13 wherein said organism is a human.

15 . The method of claim 13 wherein said introducing step comprises providing said composition to a metered dose inhaler (MDI) and discharging the composition from said MDI.

16 . The method of claim 13 comprising sterilizing an article by contacting said article with said composition.

17 . (canceled)

18 . A formulation comprising at least one fluoroalkene in accordance with Formula I:

XCF z R3- z   (I)

where X is a C2 or a C3 unsaturated, substituted or unsubstituted, alkyl radical, R is independently Cl, F, Br, I or H, and z is 1 to 3.

19 . A fragrance formulation comprising the formulation of claim 18

XCF z R3- z   (I).

20 . (canceled)

21 . A flavor formulation comprising the formulation of claim 18 .